London, England -- (SBWIRE) -- 03/27/2012 -- This report gives you access to the category-level spending outlooks, budgets, supplier selection criteria, business challenges and investment opportunities of leading purchase decision makers. The report also identifies future growth of buyers and suppliers, M&A and e-procurement. This report not only grants access to the opinions and strategies of business decision makers and competitors, but also examines their actions surrounding business priorities. The report also provides access to information categorized by region, company type and sizes.

For Sample Pages, please click or add the below link to your browser:
http://www.globalmarketsdirect.com/SamplePdfRequest.aspx?ID=Global-Pharmaceutical-Survey-2012-2013-Market-Trends-Buyer-Spend-and-Procurement-Strategies-in-the-Global-Pharmaceutical-Industry&Title=Pharmaceuticals_and_Healthcare&ReportType=Industry_Report&companyID=sbwire

Scope of the report:
The report features the opinions of global Pharmaceutical industry respondents related to the following:

Revenue growth and future developments in business structure.Merger and acquisition activity.Capital expenditure and change in staff recruitment activity.Key regions of growth.Key industry threats and opportunities.Key supplier actions and e-procurement.Annual procurement budgets and change in procurement expenditure.Change in supplier selection and procurement objectives.

Why you need this report:
Why was the report written?This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of leading global pharmaceutical industry executives. The report provides data and analysis on buyer expenditure, procurement and developments within the global pharmaceutical industry. This report includes key topics such as global pharmaceutical industry buyer expenditure and procurement behaviours and strategies. This report identifies the threats and opportunities within the global pharmaceutical industry, economic outlook trends and business confidence within global pharmaceutical industry executives. Most secondary research reports are based on general industry drivers and do not understand the industry executives’ attitude and changing behaviours, creating a gap in presenting the business outlook of the industry. In an effort to bridge this gap, ICD Research created this primary-research based report by gathering the opinions of multiple stake holders in the value-chain of the global pharmaceutical industry.

What is the current market landscape and what is changing?Growing economic concerns in the later part of 2011 in Europe and North America motivated organizations to rethink about their growth prospects for 2012. According to a World Bank projection in January 2012, world economic growth will be truncated to 2.5% in 2012 and 3.1% in 2013, as compared with a projection of 3.6% in June 2011, following the financial turmoil in Europe and weak growth prospects in emerging nations.

What are the key drivers behind recent market changes?ICD Research survey results demonstrate that respondents’ optimism of revenue growth expectations increased in 2011 by six percentage points, as compared with 2010. Additionally, respondents who expect an increase in growth have declined in 2012 by 9 percentage points as compared with 2011. This relative decrease in growth optimism may be seen as a reflection of financial performances of prominent pharmaceutical companies in the fourth quarter ended December 31, 2011 (Q4 2011).

Do follow us at facebook:
http://www.facebook.com/PharmaceuticalsandHealthcareMarketIntelligence

Visit our report store: http://www.globalmarketsdirect.com

For more details contact:
pressreleases@globalmarketsdirect.com

North America:
+1 646 395 5477
Europe:
+44 207 753 4299
+44 1204 543 533
Asia Pacific:
+91 40 6616 6782